Jump to content
RemedySpot.com

delay in approval of tasigma

Rate this topic


Guest guest

Recommended Posts

Guest guest

here are some delay news regarding fda approval of tasigma (amn-107)

i hope the delay will not be longer than the 3 months reported

best regards

giora

Reuters

Novartis cuts outlook, faces U.S. Tasigna delay

Tuesday July 17, 8:16 am ET

Novartis also said U.S. regulators had extended their review period for cancer

drug Tasigna by three months to review additional data. No new studies are

required

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...